SI0957109T1 - Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof - Google Patents

Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Info

Publication number
SI0957109T1
SI0957109T1 SI9530707T SI9530707T SI0957109T1 SI 0957109 T1 SI0957109 T1 SI 0957109T1 SI 9530707 T SI9530707 T SI 9530707T SI 9530707 T SI9530707 T SI 9530707T SI 0957109 T1 SI0957109 T1 SI 0957109T1
Authority
SI
Slovenia
Prior art keywords
intermediates
enkephalinase
inhibitors
converting enzyme
angiotensin converting
Prior art date
Application number
SI9530707T
Other languages
English (en)
Slovenian (sl)
Inventor
Gary Alan Flynn
Michael James Genin
Douglas Wade Beight
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/535,403 external-priority patent/US5641880A/en
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of SI0957109T1 publication Critical patent/SI0957109T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9530707T 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof SI0957109T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36091594A 1994-12-21 1994-12-21
US08/535,403 US5641880A (en) 1994-12-21 1995-10-24 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
EP99114227A EP0957109B1 (en) 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Publications (1)

Publication Number Publication Date
SI0957109T1 true SI0957109T1 (en) 2004-10-31

Family

ID=27001069

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9530326T SI0800527T1 (en) 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
SI9530707T SI0957109T1 (en) 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI9530326T SI0800527T1 (en) 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Country Status (23)

Country Link
US (1) US5734049A (es)
EP (1) EP0800527B1 (es)
JP (1) JP3658408B2 (es)
CN (2) CN1113894C (es)
AR (1) AR000378A1 (es)
AT (2) ATE190315T1 (es)
AU (1) AU689362B2 (es)
CA (2) CA2208569C (es)
DE (2) DE69533002T2 (es)
DK (2) DK0957109T3 (es)
ES (2) ES2216386T3 (es)
FI (1) FI121599B (es)
GR (1) GR3033329T3 (es)
HK (1) HK1066009A1 (es)
HU (1) HU227675B1 (es)
IL (6) IL139141A (es)
MX (1) MX9704677A (es)
NO (2) NO308900B1 (es)
NZ (2) NZ298245A (es)
PT (2) PT957109E (es)
SI (2) SI0800527T1 (es)
TW (1) TW401413B (es)
WO (1) WO1996019492A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US9695121B2 (en) * 2013-01-30 2017-07-04 Basf Se 2,6-bis-(aminomethyl)piperidine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA874107B (es) * 1986-06-13 1987-12-09
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
NZ241023A (en) * 1990-12-21 1994-10-26 Merrell Dow Pharma Condensed benzazepine derivatives and pharmaceutical compositions
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ES2106112T3 (es) * 1991-09-27 1997-11-01 Merrell Pharma Inc Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam

Also Published As

Publication number Publication date
DK0800527T3 (da) 2000-06-05
CN1495186A (zh) 2004-05-12
NZ334608A (en) 1999-07-29
IL139141A0 (en) 2001-11-25
US5734049A (en) 1998-03-31
SI0800527T1 (en) 2000-08-31
ES2147863T3 (es) 2000-10-01
HUT78073A (hu) 1999-08-30
JP3658408B2 (ja) 2005-06-08
CA2208569A1 (en) 1996-06-27
CA2297134A1 (en) 1996-06-27
HK1066009A1 (en) 2005-03-11
IL139142A (en) 2004-07-25
DE69515517D1 (de) 2000-04-13
NO972875D0 (no) 1997-06-20
EP0800527A1 (en) 1997-10-15
ES2216386T3 (es) 2004-10-16
FI972620A (fi) 1997-06-18
NO308900B1 (no) 2000-11-13
CA2208569C (en) 2000-07-11
NO972875L (no) 1997-08-20
WO1996019492A1 (en) 1996-06-27
FI121599B (fi) 2011-01-31
ATE190315T1 (de) 2000-03-15
ATE266040T1 (de) 2004-05-15
HU227675B1 (en) 2011-11-28
IL116428A (en) 2001-03-19
DE69533002D1 (de) 2004-06-09
GR3033329T3 (en) 2000-09-29
PT800527E (pt) 2000-06-30
DK0957109T3 (da) 2004-06-01
DE69515517T2 (de) 2000-07-06
PT957109E (pt) 2004-09-30
DE69533002T2 (de) 2005-05-04
NO20001822L (no) 1997-08-20
NO20001822D0 (no) 2000-04-07
EP0800527B1 (en) 2000-03-08
CN1241924C (zh) 2006-02-15
CN1170413A (zh) 1998-01-14
IL116428A0 (en) 1996-03-31
NO310025B1 (no) 2001-05-07
JPH10511348A (ja) 1998-11-04
NZ298245A (en) 1999-04-29
AU689362B2 (en) 1998-03-26
IL128996A0 (en) 2000-02-17
MX9704677A (es) 1997-09-30
CN1113894C (zh) 2003-07-09
AR000378A1 (es) 1997-06-18
IL139142A0 (en) 2001-11-25
AU4368596A (en) 1996-07-10
CA2297134C (en) 2004-02-10
TW401413B (en) 2000-08-11
FI972620A0 (fi) 1997-06-18
IL139141A (en) 2005-11-20

Similar Documents

Publication Publication Date Title
AP9700960A0 (en) Inhibitors of interleukin-1B converting enzyme
HK1089435A1 (en) Inhibitors of interleukin-1b converting enzyme
HUP9902254A3 (en) Inhibitors of interleukin-1beta converting enzyme
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
HUP0002953A3 (en) Method for preparation of citalopram and intermediates used for them
PL333364A1 (en) Novel compounds and method of using them
PL334975A1 (en) Application of gasto-intestinal lipase inhibitors
GB9409135D0 (en) Gamma-pyrone-acetic acid as an inhibitor of interleukin-1B converting enzyme
PL338679A1 (en) Method of obtaining l-glutamic acid by fermentation
HUP9702403A3 (en) Method of preparing retroviral protease inhibitor intermediates
ZA9610798B (en) Inhibitors of interleuken-1beta converting enzyme
IL131660A (en) Process for preparation of pesticidal intermidiates and novel intermediates therefor
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
AU4247097A (en) Methods of making hiv-protease inhibitors and intermediates for making them
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
HK1066009A1 (en) Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
ZA9510713B (en) Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
PL328053A1 (en) Method of obtaining heteroarylocarboxylic amides and esters and novel compounds
AP2002002539A0 (en) Inhibitors of interleukin-1b converting enzyme
GB9720087D0 (en) Preparation of cyclopropylethyne and intermediates for preparation of cyclopropylethyne
HUP9902707A3 (en) Inhibitors of interleukin-1beta converting enzyme
AP9901497A0 (en) Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors